CRS
Overvalued by 89.8% based on the discounted cash flow analysis.
Market cap | $8.50 Billion |
---|---|
Enterprise Value | $9.04 Billion |
Dividend Yield | $0.8 (0.470007637624111%) |
Earnings per Share | $3.75 |
Beta | 1.29 |
Outstanding Shares | 50,200,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 31.79 |
---|---|
PEG | 34.12 |
Price to Sales | 3.17 |
Price to Book Ratio | 5.22 |
Enterprise Value to Revenue | 3.2 |
Enterprise Value to EBIT | 22.54 |
Enterprise Value to Net Income | 39 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.41 |
No data
No data